PapersFlow Research Brief
Cancer and Skin Lesions
Research Guide
What is Cancer and Skin Lesions?
Cancer and skin lesions refer to a cluster of cutaneous adnexal neoplasms, including extramammary Paget's disease, cylindromatosis gene mutations, Mohs micrographic surgery applications, and diagnostic immunohistochemistry, alongside related syndromes and molecular markers such as ß-catenin mutations.
This field encompasses 53,419 works focused on adnexal neoplasms like trichoepithelioma, pilomatricoma, and sweat gland carcinoma. Studies emphasize diagnostic tools including immunohistochemistry and Mohs micrographic surgery for precise lesion management. Key areas include molecular markers like cylindromatosis gene and ß-catenin mutations associated with these skin lesions.
Topic Hierarchy
Research Sub-Topics
Extramammary Paget's Disease
This sub-topic studies clinical variants, pagetoid spread patterns, and associations with underlying visceral malignancies. Researchers investigate immunohistochemical markers like CK7/20 and HER2 for distinguishing primary from secondary disease.
Mohs Micrographic Surgery for Adnexal Tumors
Studies evaluate MMS efficacy, recurrence rates, and tissue-sparing advantages for microcystic adnexal carcinoma and sebaceous neoplasms. Research compares frozen section accuracy with paraffin processing for tumor clearance.
Cylindromatosis Gene Mutations
This sub-topic examines CYLD germline mutations in Brooke-Spiegler syndrome, genotype-phenotype correlations, and tumor suppressor functions. Researchers explore deubiquitinase activity loss in spiradenocylindrocarcinomas.
Immunohistochemistry in Adnexal Neoplasm Diagnosis
Research develops panels distinguishing follicular, sebaceous, and sweat gland tumors using p63, CK15, adipophilin. Studies address diagnostic pitfalls in syringomas versus metastatic adenocarcinomas.
ß-Catenin Mutations in Pilomatricoma
This sub-topic investigates CTNNB1 exon 3 mutations driving Wnt activation in pilomatricomas and secondary adnexal neoplasms. Researchers correlate nuclear ß-catenin expression with aggressive behavior and syndromic associations.
Why It Matters
Diagnosis and treatment of skin lesions linked to cancer impact organ transplant patients, where skin cancers represent the most common tumors, as detailed in "Skin Cancers after Organ Transplantation" by Euvrard et al. (2003), which covers squamous-cell and basal-cell carcinomas along with management strategies. Vismodegib demonstrates tumor responses in 43% of patients with locally advanced or metastatic basal-cell carcinoma in the Erivance BCC trial (NCT00833417), as reported in "Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma" by Sekulić et al. (2012). Confocal imaging-guided laser ablation offers a targeted approach for basal cell carcinomas, evaluated ex vivo in "Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study" by Sierra et al. (2014). These applications aid in distinguishing benign from malignant lesions, reducing unnecessary biopsies as shown in sonography studies for solid breast nodules that inform broader lesion classification.
Reading Guide
Where to Start
"Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma" by Nielsen et al. (2004) serves as the starting point because its 2641 citations establish foundational expression profiling for carcinoma subtypes applicable to skin lesion diagnostics.
Key Papers Explained
"Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma" by Nielsen et al. (2004) provides marker profiling that informs diagnostics in "Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study" by Sierra et al. (2014), which tests ablation techniques on basal cell lesions. "Skin Cancers after Organ Transplantation" by Euvrard et al. (2003) builds context for high-risk populations treated in "Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma" by Sekulić et al. (2012), linking epidemiology to targeted therapies. "Trabecular Carcinoma of the Skin" by Toker (1972) describes morphology foundational to modern classifications.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current focus remains on refining Mohs surgery and immunohistochemistry for adnexal neoplasms like sweat gland carcinoma, with no recent preprints available. Emphasis persists on molecular markers such as ß-catenin mutations and cylindromatosis gene in diagnostic panels.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Immunohistochemical and Clinical Characterization of the Basal... | 2004 | Clinical Cancer Research | 2.6K | ✓ |
| 2 | Risk Factors for Breast Cancer in Women with Proliferative Bre... | 1985 | New England Journal of... | 1.8K | ✕ |
| 3 | Solid breast nodules: use of sonography to distinguish between... | 1995 | Radiology | 1.8K | ✕ |
| 4 | Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinoma... | 2014 | Journal of Investigati... | 1.7K | ✓ |
| 5 | Skin Cancers after Organ Transplantation | 2003 | New England Journal of... | 1.6K | ✕ |
| 6 | Controls of Hair Follicle Cycling | 2001 | Physiological Reviews | 1.5K | ✕ |
| 7 | Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms | 1969 | Annals of Internal Med... | 1.5K | ✕ |
| 8 | Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carci... | 2012 | New England Journal of... | 1.4K | ✓ |
| 9 | Trabecular Carcinoma of the Skin | 1972 | Archives of Dermatology | 1.4K | ✕ |
| 10 | A Comprehensive Guide for the Accurate Classification of Murin... | 2001 | Journal of Investigati... | 1.4K | ✕ |
Frequently Asked Questions
What role does immunohistochemistry play in diagnosing skin lesions?
Immunohistochemistry aids in characterizing basal-like subtypes of invasive carcinomas relevant to skin lesion diagnostics. "Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma" by Nielsen et al. (2004) profiles expression markers distinguishing carcinoma groups. This method supports precise identification of adnexal neoplasms in dermatology.
How does Mohs micrographic surgery apply to skin cancer treatment?
Mohs micrographic surgery provides margin-controlled excision for skin cancers like basal cell carcinoma. It aligns with studies on trabecular carcinoma and sweat gland neoplasms in the adnexal neoplasms cluster. The technique minimizes tissue removal while ensuring complete tumor clearance.
What are risk factors for cancer in patients with proliferative lesions?
Women with proliferative breast disease face elevated breast cancer risk based on reevaluation of 10,366 biopsies with 17-year median follow-up. "Risk Factors for Breast Cancer in Women with Proliferative Breast Disease" by Dupont and Page (1985) identifies key factors in this cohort. Similar proliferative patterns inform cutaneous lesion risk assessment.
What is the significance of ß-catenin mutations in skin lesions?
ß-Catenin mutations associate with adnexal neoplasms such as pilomatricoma and trichoepithelioma. These molecular markers aid in classifying cutaneous tumors. Diagnostic panels incorporate such mutations for accurate lesion typing.
How prevalent are skin cancers post-organ transplantation?
Skin cancers are the most common neoplasms in organ transplant recipients. "Skin Cancers after Organ Transplantation" by Euvrard et al. (2003) details epidemiology of squamous-cell, basal-cell carcinomas, and others. Management focuses on prevention and early intervention in this high-risk group.
Open Research Questions
- ? How can confocal imaging improve real-time margin detection during ablation of basal cell carcinomas beyond ex vivo studies?
- ? What molecular pathways link cylindromatosis gene mutations to specific adnexal neoplasm subtypes?
- ? Which immunohistochemistry panels best differentiate extramammary Paget's disease from other cutaneous mimics?
- ? How do ß-catenin mutations influence prognosis in sweat gland carcinomas?
- ? What long-term outcomes follow vismodegib treatment in advanced basal cell carcinoma post-transplantation?
Recent Trends
The field maintains 53,419 works with no specified 5-year growth rate available.
High-citation papers from 2004-2014, such as "Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma" by Nielsen et al. (2641 citations), continue to anchor diagnostics.
No recent preprints or news coverage in the last 12 months indicates steady reliance on established studies like vismodegib trials.
Research Cancer and Skin Lesions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cancer and Skin Lesions with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers